10-Year Overview
T184 | |||||||||||
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
Order situation | |||||||||||
Order book1 | EUR millions | 473,2 | 530.0 | 569.6 | 508.4 | 391.3 | 358.3 | 379.2 | 329.1 | 302.4 | 295.8 |
Income statement | |||||||||||
Revenue | EUR millions | 1,155.1 | 1,222.8 | 1,243.0 | 1,091.9 | 952.2 | 1,100.1 | 1,084.1 | 1,017.1 | 894.9 | 889.6 |
thereof EMEA | EUR millions | 477.3 | 514.7 | 489.2 | 462.4 | 409.5 | 486.0 | 494.8 | 485.9 | 432.0 | 416.0 |
thereof Americas | EUR millions | 530.4 | 534.5 | 574.2 | 456.8 | 385.5 | 450.8 | 441.5 | 411.3 | 381.6 | 395.3 |
thereof Asia-Pacific | EUR millions | 147.4 | 173.6 | 179.6 | 172.8 | 157.2 | 163.4 | 147.8 | 119.9 | 81.3 | 78.2 |
Cost of materials ratio | % | 43.3 | 45.0 | 48.0 | 45.8 | 43.8 | 43.4 | 43.6 | 41.2 | 39.4 | 40.8 |
Personnel cost ratio | % | 29.3 | 26.3 | 24.9 | 26.1 | 31.3 | 27.5 | 25.9 | 26.5 | 27.3 | 26.3 |
Adjusted EBIT2 | EUR millions | 92.3 | 97.5 | 99.0 | 113.8 | 45.3 | 136.1 | 164.5 | 166.0 | 147.7 | 147.9 |
Adjusted EBIT margin2 | % | 8.0 | 8.0 | 8.0 | 10.4 | 4.8 | 12.4 | 15.2 | 16.3 | 16.5 | 16.6 |
EBIT | EUR millions | 57.3 | 76.1 | 76.5 | 92.1 | 20.1 | 96.7 | 133.5 | 137.8 | 120.0 | 124.8 |
EBIT margin | % | 5.0 | 6.2 | 6.2 | 8.4 | 2.1 | 8.8 | 12.3 | 13.5 | 13.4 | 14.0 |
Financial result | EUR millions | -23.3 | -22.7 | -12.6 | -12.4 | – 14.8 | – 15.5 | – 11.7 | – 16.1 | – 14.6 | – 17.2 |
Adjusted tax rate2 | % | 40.8 | 41.3 | 35.2 | 28.6 | 20.3 | 27.1 | 24.9 | 30.0 | 28.9 | 32.1 |
Adjusted profit for the period2 | EUR millions | 40.9 | 43.9 | 56.0 | 72.3 | 24.3 | 87.8 | 114.8 | 105.0 | 94.6 | 88.7 |
Adjusted EPS2 | EUR | 1.28 | 1.37 | 1.75 | 2.27 | 0.77 | 2.76 | 3.61 | 3.29 | 2.96 | 2.78 |
Profit for the period | EUR millions | 14.8 | 27.9 | 39.2 | 56.1 | 5.5 | 58.4 | 91.8 | 119.8 | 75.9 | 73.8 |
EPS | EUR | 0.46 | 0.87 | 1.23 | 1.76 | 0.18 | 1.83 | 2.88 | 3.76 | 2.38 | 2.31 |
NORMA Value Added (NOVA) | EUR millions | -38.8 | -43.6 | -27.1 | 16.0 | – 46.4 | 17.3 | 60.8 | 54.9 | 53.1 | 48.3 |
Return on Capital Employed (ROCE)3 | % | 8.8 | 9.3 | 9.7 | 11.9 | 4.6 | 13.0 | 17.2 | 18.9 | 17.7 | 19.3 |
R&D expense | EUR millions | 50.8 | 44.3 | 40.6 | 38.0 | 29.0 | 31.2 | 30.5 | 29.4 | 28.8 | 25.4 |
R&D ration (related to sales)4 | % | 4.4 | 3.6 | 3.3 | 3.5 | 3.1 | 4.7 | 4.5 | 4.6 | 5.4 | 4.7 |
Investment ratio in relation to sales (without acquisitions) | % | 4.6 | 5.0 | 4.3 | 4.3 | 4.3 | 5 | 5.8 | 4.7 | 5.4 | 4.7 |
10-Year Overview (Continued) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
Balance sheet1 | |||||||||||
Total assets | EUR millions | 1,436.6 | 1,493.3 | 1,560.7 | 1,498.2 | 1,414.7 | 1,514.3 | 1,471.7 | 1,312.0 | 1,337.7 | 1,167.9 |
Equity | EUR millions | 721.4 | 693.4 | 705.4 | 668.6 | 589.5 | 629.5 | 602.4 | 534.3 | 483.6 | 429.8 |
Equity ratio | % | 50.2 | 46.4 | 45.2 | 44.6 | 41.7 | 41.6 | 40.6 | 40.7 | 36.2 | 36.8 |
Net debt | EUR millions | 329.2 | 345.4 | 349.8 | 318.5 | 338.4 | 420.8 | 400.3 | 344.9 | 394.2 | 360.9 |
Working capital | EUR millions | 236.5 | 230.9 | 230.4 | 189.5 | 160.8 | 192.5 | 179.2 | 158.2 | 144.5 | 151.9 |
Working capital related to sales | % | 20.5 | 18.9 | 18.5 | 17.4 | 16.9 | 17.5 | 16.5 | 15.6 | 16.1 | 17.1 |
Cash flow | |||||||||||
Cash flow from operating activities | EUR millions | 137.0 | 118.9 | 76.6 | 108.4 | 133.5 | 137.1 | 130.8 | 146.0 | 149.2 | 128.2 |
Cash flow from investing activities | EUR millions | -63.5 | -59.8 | -44.5 | -45.2 | – 39.1 | – 57.0 | – 129.5 | – 70.8 | -133.8 | – 44.5 |
Cash flow from financing activities | EUR millions | -114.1 | -57.9 | -54.5 | -71.1 | – 81.0 | – 93.2 | 31.3 | – 77.7 | 49.6 | – 70.4 |
Net operating cash flow | EUR millions | 105.4 | 87.3 | 65.3 | 99.8 | 78.3 | 122.9 | 124.4 | 132.9 | 148.5 | 134.7 |
Non financial figures | |||||||||||
Core workforce1 | Number | 6,041 | 5,994 | 6,175 | 6,191 | 6,635 | 6,523 | 6,901 | 6,115 | 5,450 | 5,121 |
Temporary workers1 | Number | 1,553 | 2,011 | 2,532 | 2,012 | 2,155 | 1,998 | 1,964 | 1,552 | 1,214 | 1,185 |
Total workforce1 | Number | 7,594 | 8,005 | 8,707 | 8,203 | 8,790 | 8,521 | 8,865 | 7,667 | 6,664 | 6,306 |
Invention applications5 | Number | 25 | 20 | 21 | 25 | 22 | 22 | 32 | 33 | n/a | n/a |
Accepted customer complaints | Month per P/D | 2.8 | 3.9 | 3.7 | 5.1 | 4.7 | 6.4 | 7.0 | 9.0 | 8.0 | n/a |
CO2 emissions (Scope 1 and 2)6,7 | t CO2 eq | 4,171 | 5,064 | 4,879 | 43,449 | 49,875 | 54,494 | 51,018 | n/a | n/a | n/a |
10-Year Overview (Continued) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
Share data | |||||||||||
Last price1,8 | EUR | 14,94 | 16.03 | 17.00 | 33.88 | 41.90 | 38.00 | 43.20 | 56.00 | 40.60 | 51.20 |
Market capitalization1,8 | EUR millions | 476 | 511 | 542 | 1,079 | 1,334 | 1,211 | 1,376 | 1,783 | 1,292 | 1,630 |
Dividend9 | EUR | 0.40 | 0.45 | 0.55 | 0.75 | 0.70 | 0.04 | 1.10 | 1.05 | 0.95 | 0.90 |
Payout ratio9 | % | 31.2 | 32.7 | 31.3 | 33.0 | 91.7 | 1.5 | 30.5 | 31.9 | 32.0 | 32.3 |
Price-earnings ratio at year end | 32.5 | 18.4 | 13.8 | 19.3 | 232.7 | 20.8 | 15.0 | 14.9 | 17.0 | 22.1 | |
Number of shares issued | 31,862,400 | 31,862,400 | 31,862,400 | 31,862,400 | 31,862,400 | 31,862,400 | 31,862,400 | 31,862,400 | 31,862,400 | 31,862,400 | |
1_Figures as of balance sheet date Dec 31. 2_Since 2020: Adjusted exclusively for certain expenses related to realized acquisitions; Details regarding the adjustments can be found in the corresponding Annual Reports. 3_Adjusted EBIT in relation to the average capital employed. 4_Up to and including 2019 in relation to sales of the former EJT sales channel. since 2020 in relation to total sales. 5_The number of invention disclosures has served as a key figure for measuring the Group's innovative capacity since mid-2016, replacing the number of new patent applications, which had become less meaningful due to the change in patent strategy. No comparative figures are available for previous years. 6_The CO2 emissions for the target value are reported in accordance with the GHG Protocol (market-based, Scope 1 and Scope 2). Scope 1 includes only emissions from natural gas and liquid gas and Scope 2 emissions from purchased electricity and district heating. When recording emissions, only emissions relating to the production sites are taken into account. Since January 2022, NORMA Group has purchased electricity from renewable energy sources at all production sites. NORMA Group purchases “Energy Attribute Certificates” for this purpose. These are also included in the target value. 7_ The methodology described in footnote 6 was used in the management system until the end of 2024 based on the forecast for CO2 emissions of “below 9,600 tons of CO2 equivalents” issued in fiscal year 2024. The change in the calculation basis in connection with the first-time application of the European Sustainability Reporting Standards (ESRS) will be included in the 2025 Annual Report. As a result, emissions from the greenhouse gas balance in accordance with the Greenhouse Gas (GHG) Protocol initiative will be reported in future annual reports in the management system in the Scope 1 to Scope 3 categories for all locations worldwide. 8_Xetra price. 9_Subject to approval by the Annual General Meeting. | |||||||||||
Legend
These contents are part of the Non-financial Group Report and were subject to a separate limited assurance examination.